Equities

Valiant Laboratories Ltd

VALIANTLAB:NSI

Valiant Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)119.77
  • Today's Change-0.63 / -0.52%
  • Shares traded84.36k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,8213,3392,082
OPERATING EXPENSES
Cost of revenue total1,6832,7731,675
Selling, general and admin. expenses, total434622
Depreciation/amortization201616
Unusual expense(income)------
Other operating expenses, total17916983
Total operating expense1,9243,0041,797
Operating income(104)335285
Other, net629.2917
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(7.7)381302
Provision for income taxes(11)9175
Net income after taxes3.20290227
Minority interest------
Net income before extra. Items3.20290227
Total extraordinary items------
Net income3.20290227
Inc.avail. to common excl. extra. Items3.20290227
Inc.avail. to common incl. extra. Items3.20290227
EPS RECONCILIATION
Basic/primary weighted average shares383316
Basic/primary eps excl. extra items0.088.9114
Basic/primary eps incl. extra items0.088.9114
Dilution adjustment------
Diluted weighted average shares383316
Diluted eps excl. extra items0.088.9114
Diluted eps incl. extra items0.088.9114
COMMON STOCK DIVIDENDS
DPS - common stock primary issue--0--
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.782.530.24
SUPPLEMENTAL INCOME
Depreciation, supplemental201616
Total special items------
NORMALISED INCOME
Normalized income before taxes(7.7)381302
Effect of special items on income taxes------
Income tax excluding impact of special items(11)9175
Normalized income after tax3.20290227
Normalized income avail. to common3.20290227
Basic normalized EPS0.088.9114
Diluted normalized EPS0.088.9114
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.